Evidence map›Paper›PMID 36942752›Full record

ArticleJournal of the American Heart Association2023

Circ-myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia-Inducible Factor-1α Expression.

Yan Xing, Jing Qi, Xiaohan Cheng, Xinyue Song, Jingya Zhang, Songyue Li, Xiaoting Zhao, Ting Gong, Jiaxin Yang, Chong Zhao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. CircRNA-mediated regulation of cardiovascular disease.Frontiers in cardiovascular medicine · 2024
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yan XingDepartment of Pharmacology Harbin Medical University-Daqing Daqing Heilongjiang China.
Jing QiDepartment of Pharmacology Harbin Medical University-Daqing Daqing Heilongjiang China.
Xiaohan ChengSchool of Pharmacy Harbin Medical University-Daqing Daqing Heilongjiang China.ORCID 0000-0001-8070-2755
Xinyue SongCollege of Pharmacy, Harbin Medical University Harbin China.
Jingya ZhangDepartment of Pharmacology Harbin Medical University-Daqing Daqing Heilongjiang China.
Songyue LiDepartment of Pharmacology Harbin Medical University-Daqing Daqing Heilongjiang China.
Xiaoting ZhaoDepartment of Medical Genetics Harbin Medical University-Daqing Daqing Heilongjiang China.
Ting GongDepartment of Medical Genetics Harbin Medical University-Daqing Daqing Heilongjiang China.
Jiaxin YangDepartment of Medical Genetics Harbin Medical University-Daqing Daqing Heilongjiang China.
Chong ZhaoLibrary of Harbin Medical University-Daqing Daqing Heilongjiang China.
Wei XinCollege of Pharmacy, Harbin Medical University Harbin China.
Daling ZhuCollege of Pharmacy, Harbin Medical University Harbin China.
Xiaodong ZhengDepartment of Medical Genetics Harbin Medical University-Daqing Daqing Heilongjiang China.ORCID 0000-0002-6103-9836
Harbin Medical University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Aberrant expression of circular RNAs (circRNAs) contributes to the initiation and progression of pulmonary hypertension (PH). Hypoxia-inducible factor (HIF) is a well-known modulator of hypoxia-induced PH. The role and underlying mechanism of circRNAs in the regulation of HIF expression remains elusive. Methods and Results We profiled pulmonary artery transcriptomes using RNA sequencing and screened circRNAs associated with hypoxia treatment. The expression of a novel circRNA, circ_chr11_67292179-67294612 (circ-myh8), was increased by hypoxia in a time-dependent manner. We evaluated the effects of circ-myh8 overexpression by adeno-associated virus or inhibition by short hairpin RNA on proliferation and cell cycling in mice and pulmonary artery smooth muscle cells. Overexpression of circ-myh8 promotes PH under normoxia, and disruption of circ-myh8 by short hairpin RNA mitigates PH in chronic hypoxic mice. Biologically, circ-myh8 induces the proliferation and cell-cycle progression of pulmonary artery smooth muscle cells in vivo and in vitro. Mechanistically, RNA pull-down and RNA immunoprecipitation assays were used to examine the interaction of circRNAs with the binding protein KAT7 (lysine acetyltransferase 7). The acetylation level of lysine 5 of histone H4 in the transcriptional initiation region of HIF1α was determined by chromatin immunoprecipitation assay followed by reverse transcription-quantitative polymerase chain reaction. Circ-myh8 acts as a modular scaffold to recruit histone acetyltransferase KAT7 to the promoters of HIF1α, which elicits acetylation of lysine 5 of histone H4 in their promoters. Conclusions Our findings not only reveal the pivotal roles of circ-myh8 in governing histone modification in anti-PH treatment but also advocate triggering the circ-myh8/KAT7/HIF1α pathway to combat PH.

Indexed as

Histone AcetyltransferasesHypertension, PulmonaryHypoxia-Inducible Factor 1, alpha SubunitMyosin Heavy ChainsRNA, CircularAnimalsCell ProliferationHistonesHypoxiaLysineMiceRNA, Small InterferingHistone AcetyltransferasesHistonesHypoxia-Inducible Factor 1, alpha SubunitKat7 protein, mouseLysineMyosin Heavy ChainsRNA, CircularRNA, Small Interferingcircular RNAhistone modificationKAT7pulmonary hypertension

Identifiers

PMID36942752
PMCPMC10122881
OpenAlexW4328049042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.